Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group
Atul B. Shinagare(Brigham and Women's Hospital), Andrea Rockall(Imperial College Healthcare NHS Trust), Stéphanie Nougaret(Inserm), Olga R. Brook(Beth Israel Deaconess Medical Center), Evis Sala(Università Cattolica del Sacro Cuore), Gaiane M. Rauch(The University of Texas MD Anderson Cancer Center), Hyesun Park(Brigham and Women's Hospital), Rosemarie Forstner(Inserm), Priyanka Jha(Santosh University), Aradhana M. Venkatesan(National Institutes of Health), Caroline Reinhold(McGill University Health Centre), Isabelle Thomassin‐Naggara(Université Claude Bernard Lyon 1), Susanna I. Lee(Health Advances (United States)), Aki Kido(Kyoto University Hospital), Elizabeth A. Sadowski(University of Wisconsin–Madison), Lucia Manganaro(Sapienza University of Rome), Jeanne M. Horowitz(Northwestern University), Sumer Wallace, Marcia C. Javitt(Sunnybrook Health Science Centre), Katherine E. Maturen(Inserm), Neil S. Horowitz(Brigham and Women's Hospital), Olivera Nikolić(University of Novi Sad), Liina Pōder(University of California, San Francisco), H. Alberto Vargas(Memorial Sloan Kettering Cancer Center), Yulia Lakhman(Memorial Sloan Kettering Cancer Center)
Cited by 30
Related Papers
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
|Annals of Oncology|2015|698